StockWatch
·
HomeLiveWeekly

NATCO PHARMA LTD.

BSE: 524816

OverviewP/LShare Hold
values in crores

Revenue & Profit Trend

in crores
RevenueExpenditureNet Profit
-70.95442.85956.651.5KQ2 FY2025Q3 FY2025Q4 FY2025Q1 FY2026Q2 FY2026Q3 FY2026Q4 FY2026

Margin Trend

percentage
OPM %NPM %
-26.413.9634.3264.69Q2 FY2025Q3 FY2025Q4 FY2025Q1 FY2026Q2 FY2026Q3 FY2026Q4 FY2026
PeriodQ4 FY2026Q3 FY2026Q2 FY2026Q1 FY2026Q4 FY2025Q3 FY2025Q2 FY2025
INCOME
Revenue608.80+15.1%528.80-58.2%1.3K+6.0%1.2K+3.0%1.2K+184.0%407.60-68.5%1.3K
Other Income72.90+31.8%55.30-40.7%93.30+56.5%59.60-4.0%62.10-63.0%168.00+226.8%51.40
Total Income681.70+16.7%584.10-57.0%1.4K+8.4%1.3K+2.7%1.2K+111.9%575.60-57.2%1.3K
EXPENSES
Expenditure571.70+24.6%458.90-40.5%771.60+8.8%709.40+1.5%698.70+64.3%425.30-22.3%547.10
Tax-99.60-644.3%18.30-78.5%85.10+8.0%78.80-15.0%92.70+265.0%25.40-81.3%135.80
PROFIT
PBT110.00-12.1%125.20-78.6%586.00+7.9%542.90+4.2%520.80+246.5%150.30-81.1%796.90
Net Profit209.60+96.1%106.90-78.7%500.90+7.9%464.10+8.4%428.10+242.8%124.90-81.1%661.10
KEY METRICS
OPM %15.18%-7.57pp22.75%-20.95pp43.70%-1.55pp45.25%-3.24pp48.49%+64.39pp-15.90%-70.08pp54.18%
NPM %30.75%+12.45pp18.30%-18.60pp36.90%-0.16pp37.06%+1.96pp35.10%+13.40pp21.70%-27.49pp49.19%
EPS11.70+96.0%5.97-78.7%27.97+8.0%25.91+8.4%23.90+242.9%6.97-81.1%36.91

Corporate Events

Board MeetingNATCOPHARM
2026
29May

Board Meeting

The board meeting is scheduled to consider and approve the A…

BSE Filing ↗
Board MeetingNATCOPHARM
2026
24Mar

Board Meeting

To consider and approve the Scheme of Arrangement for the de…

BSE Filing ↗
DividendNATCOPHARM
2025
20Nov

₹1.5 / share

BSE Filing ↗
DividendNATCOPHARM
2025
18Feb

₹1.5 / share

BSE Filing ↗
DividendNATCOPHARM
2025
12Feb

₹3 / share

BSE Filing ↗
DividendNATCOPHARM
2024
25Nov

₹1.5 / share

BSE Filing ↗
DividendNATCOPHARM
2024
23Aug

₹3 / share

BSE Filing ↗
Board MeetingNATCOPHARM
2024
27May

Board Meeting

Approval of the Audited Financial Results for the quarter an…

BSE Filing ↗
DividendNATCOPHARM
2024
26Feb

₹1.25 / share

BSE Filing ↗
Board MeetingNATCOPHARM
2024
14Feb

Board Meeting

Consideration of Unaudited Financial Results for the quarter…

BSE Filing ↗
DividendNATCOPHARM
2023
24Nov

₹1.25 / share

BSE Filing ↗
Board MeetingNATCOPHARM
2023
14Nov

Board Meeting

consideration and approval of The Unaudited Financial Result…

BSE Filing ↗
DividendNATCOPHARM
2023
22Aug

₹7 / share

BSE Filing ↗
DividendNATCOPHARM
2023
9Aug

₹7 / share

BSE Filing ↗